Dr. Mahler is the Founder, CEO, and Board Member of ten23 health AG, a sustainable pharmaceutical development partner. He is adjunct faculty at the Universities of Frankfurt and Basel, serves as a Scientific Expert (Ph.Eur.) at EDQM, and is on the boards of Bionter & KriyaBio. Previously, he led the Drug Product Services unit at Lonza AG, Pharmaceutical Development at Roche, and was Principal Scientist at Merck KGaA. He holds a Pharmacy degree and a Ph.D. in Toxicology from the University of Mainz.